Ribavirin
Back to searchMolecule Structure
Scientific Name
Ribavirin
Description of the Drug
Ribavirin is a guanosine nucleoside used to treat some forms of Hepatitis C.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00811
http://www.drugbank.ca/drugs/DB00811
Brand Name(s)
Copegus, Rebetol, Ribapak, Ribasphere, Ribavarin, Ribavirin, Ribofluranosyl Carboxamide, Tribavirin, Viramid, Virazid, Virazole
Company Owner(s)
Hoffmann La Roche Inc, Teva Pharmaceuticals Usa Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Sandoz Inc, Navinta Llc, Chartwell Rx Sciences Llc, Merck Sharp And Dohme Corp, Aurobindo Pharma Ltd, Schering Corp, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hepatitis C virus NS5B RNA-dependent RNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL5375 |
| RNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2363073 |
| Inosine-5′-monophosphate dehydrogenase 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1822 |
Clinical Trial(s)
Unichem Links
| Atlas | Ribavirin | ||||
| SureChEMBL | SCHEMBL3727 | ||||
| PharmGKB | PA451241 | ||||
| Human Metabolome Database | HMDB0014949 | ||||
| DrugBank | DB00811 | ||||
| PubChem: Thomson Pharma | 14798456 | 15122005 | |||
| PubChem | 37542 | ||||
| Mcule | MCULE-9495128592 | ||||
| LINCS | LSM-5701 | ||||
| Nikkaji | J17.798I | ||||
| PDBe | RBV | ||||
| BindingDB | 50154375 | ||||
| EPA CompTox Dashboard | DTXSID8023557 | ||||
| DrugCentral | 2373 | ||||
| Brenda | 239340 | 1304 | 101995 | ||
| ChemicalBook | CB0689324 | ||||
| Guide to Pharmacology | 6842 | ||||
| rxnorm | REBETOL | VIRAZOLE | COPEGUS | RIBASPHERE | RIBAVIRIN |
| PubChem: Drugs of the Future | 99431523 | ||||
| ChEBI | 63580 | ||||
| ZINC | ZINC000001035331 |
